Brief: Vitrolife Q2 EBITDA Up At SEK 273 Million
July 15 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT Q2, 2022: TOGETHER FOR SUCCESSFUL GROWTH
* Q2 SALES OF SEK 829 (382) MILLION
* Q2 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) WAS SEK 273 (134) MILLION
Source text for Eikon: ID:nWkr2bnRzp
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))